Di-Cola Simone, Lapenna Lucia, Spigaroli Margherita, Nardelli Silvia, Merli Manuela
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome 00185, Italy.
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome 00185, Italy.
Dig Liver Dis. 2025 Jul;57(7):1434-1441. doi: 10.1016/j.dld.2025.04.023. Epub 2025 May 3.
Ascites is the most common cause of decompensation in cirrhosis. Elderly patients with cirrhosis usually have multiple comorbidities, which can be a barrier to many therapeutic options. Therefore, the treatment choices available to these patients are limited and must be carefully selected on a case-by-case basis. In order to explore the management of ascites in elderly patients with cirrhosis in real-life, we conducted a survey among members of the AISF in July 2024, concerning patients with cirrhosis aged >70 years with ascites. Physicians were invited to anonymously answer 49 questions on several topics. Data from 22 centers revealed that approximately 20 % of these patients had intractable ascites, primarily caused by renal failure, hypotension, and hepatic encephalopathy. Diuretics were used in 62 % of cases, while advanced therapies such as TIPS or transplantation were rare due to frailty and comorbidities. The dose and frequency of home albumin infusion was heterogeneous across centers, showing a non-uniform approach. Malnutrition was reported in nearly 50 % of patients, but nutritional interventions were limited. Non-academic centers reported reduced availability to different therapeutic options, highlighting disparities in care. This study underscores the need for a multidisciplinary approach and increased outpatient support to address the complex needs of elderly patients with cirrhosis and ascites.